Concerns raised over 2D barcodes missing from medicines packaging Pharmacy staff have raised concerns that 2D barcodes are no longer being printed on all medicines destined for the UK supply chain.

Concerns raised over 2D barcodes missing from medicines packaging

buff.ly/ADWj8w0

#barcodes #2Dbarcodes #RPS #medicines #medicinessafety #pharmaceuticals

The dangers of propranolol for anxiety In November 2024, a coroner in Blackpool gave a stark warning about the risks of prescribing propranolol for anxiety after a young women died from an overdose. In a report on the death of 17-year-old…

*The dangers of propranolol for anxiety*

In this feature, #EmmaWilkinson looks into the issue of prescribing propranolol for anxiety, despite expert warnings

#ukpharmacy #medicinessafety #anxiety

Class 1 recall issued for quetiapine oral suspension The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 1 recall notice for all batches of quetiapine oral suspension (Seroquel; Eaststone Limited), after the manufacturer…

#MHRA issues class 1 recall notice for all batches of #quetiapine oral suspension (#Seroquel; #Eaststone)

#drugsafety #medicinessafety #medicinerecall #mentalhealth #NHS #ukhealthcare

Prescribing error led to death of baby, says coroner A coroner has raised concerns after a baby died as the result of a prescribing error in hospital, after being wrongly prescribed sodium acid phosphate instead of sodium chloride.  In a ‘Prevention of…

Coroner raises concerns after a prescribing error in hospital led to the death of a baby, after being wrongly prescribed sodium acid phosphate instead of sodium chloride

#PFD #medicinessafety #prescribingerror

Community pharmacy in focus: research insights on improving patient care Globally, community pharmacists’ role — and that of their teams — continues to evolve beyond the delivery of purely traditional pharmacy services, becoming a key access point for public health and…

This article, by #DianeAshiruOredope & #JamesDavies, highlights recent studies published in the #IJPP and abstracts presented at the #RPS Annual Conference

#AMS #chronicdisease #neurodiversity #prescribing #medicinessafety

Health news round-up: Huntington’s disease breakthrough and how to tackle medicines misinformation With autumn well and truly underway, The Pharmaceutical Journal has covered some important seasonal challenges this week — from medicines shortages and funding to supporting trainees on new MPharm…

A round up of health news from the week, including a gene therapy breakthrough in the treatment of Huntington's disease and how to tackle medicines misinformation

#ukpharmacy #medicinessafety #huntingtonsdisease

#WPD2025 #MedicinesSafety #MSO #Pharmacist #HospitalPharmacist #WorldPharmacistDay #WorldPharmacistWeek #HealthcareHeroes #UHLGPharmacy #ThinkHealthThinkPharmacist

#WPD2025 #MedicinesSafety #MSO #Pharmacist #HospitalPharmacist #WorldPharmacistDay #WorldPharmacistWeek #HealthcareHeroes #UHLGPharmacy #ThinkHealthThinkPharmacist

Second recall in six months hits Fabupharm Justicia Shipena A routine inspection conducted on Monday uncovered several shortcomings in Fabupharm Namibia (Pty) Ltd’s oral liquid dosage block, the Namibia Medicines Regulatory Council (NMRC) has said. As a result, the NMRC instructed the company to recall all its oral liquid products and halt production on the affected liquid line until the issues are corrected. “The inspection of the oral liquid dosage block observed shortcomings which necessitated various corrective and preventative actions,” said Fransina Nambahu, registrar of the NMRC. The directive follows pressure from member of parliament Job Amupanda, who last week urged the council to act after claiming he had evidence that Fabupharm’s children’s paracetamol syrup was unsafe. Nambahu said production may only resume once the highlighted issues are fully addressed in line with standard manufacturing requirements. She said the NMRC is committed to ensuring access to safe, effective, and quality-assured medicines for all Namibians. “Further information regarding the Council’s fulfilment of this mandate in this regard will be provided in due course.” Fabupharm last week maintained that its children’s paracetamol syrup is safe. The Otjiwarongo-based company had stated it had not received any formal communication from the Council indicating that its product was defective, unsafe, or non-compliant with regulations. At that time, the company maintained that its paracetamol syrup is manufactured according to strict international Good Manufacturing Practice (GMP) standards and follows guidelines from the World Health Organisation (WHO) and local regulatory frameworks. Amupanda on Wednesday welcomed the Council’s decision. “I welcome the implementation of my instructions to the Minister and the Namibia Medicine Regulatory Council (NMRC) with regard to the products of Fabupharm as taken on Monday, 02 June 2025, as soon as the Minister returns to the country,” he said. He said no one should play with the health of people, especially children. This is not the first time Fabupharm has been ordered to recall a product. In January, the Ministry of Health and Social Services recalled a facial scrub due to quality concerns.  The scrub, chlorhexidine 4% 20L, was manufactured by Fabupharm in Otjiwarongo. According to a letter from the ministry’s deputy director of operations, Barnabas Iitula, dated 16 January, the recall followed multiple complaints from end-users.

#Recall #Fabupharm #MedicinesSafety #PublicHealth #NMRC

The dangers of propranolol for anxiety In November 2024, a coroner in Blackpool gave a stark warning about the risks of prescribing propranolol for anxiety after a young women died from an overdose. In a report on the death of 17-year-old…

Despite warnings issued five years ago about the risks of prescribing #propranolol to treat anxiety, experts say there is still not enough being done to protect patients

#mentalhealth #medicinessafety

More than 90% of pharmacists oppose self-selection of P medicines, says PDA Pharmacists “overwhelmingly” oppose the self-selection of Pharmacy (P) medicines in pharmacies, according to a report published by the Pharmacists’ Defence Association (PDA). In its report — ‘Beyond…

A Pharmacists' Defence Association report reveals that its members overwhelmingly oppose the self-selection of P medicines, owing to concerns over patient safety, inappropriate use and increased risk of harm
#ukpharmacy #Pmedicines #medicinessafety

The dangers of propranolol for anxiety In November 2024, a coroner in Blackpool gave a stark warning about the risks of prescribing propranolol for anxiety after a young women died from an overdose. In a report on the death of 17-year-old…

In this week's feature, #EmmaWilkinson looks into the issue of prescribing propranolol for anxiety, despite expert warnings
#ukpharmacy #medicinessafety #anxiety

Thank you to our reviewers | Drug and Therapeutics Bulletin An online journal that publishes independent evaluations of drug and medicine treatments, and advice on prescribing. Publishing commissioned-only content.

I’m proud to be listed as a reviewer for the BMJ Drug & Therapeutics Bulletin on their annual list of reviewers.

I ❤️ DTB bulletins & their accompanying podcasts.

#ClinicalEffectiveness #MedicinesSafety #EvidenceBasedMedicine
#Therapeutics #Drugs #Medicines #Pharmacy

dtb.bmj.com/pages/thank-...